跳转至内容
Merck
CN

926248

Redox Responsive Poly(ethylene glycol)-block-poly(lactide-alt-glycolide)

PEG average Mn 5000, PLGA Mn 15000

别名:

Drug release, PEG-PLGA with disulfide linkage, PEG-SS-PLGA, Stimuli-responsive

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
CH3O(C2H4O)nC7H12O4S2(C5H6O4)m
UNSPSC Code:
12352112
NACRES:
NA.23
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


form

powder, chunks or granules

Quality Level

mol wt

PEG average Mn 5000, PLGA Mn 15000

storage temp.

2-8°C

SMILES string

O=C(C(C)OC(CO[H])=O)OCCSSCCOC(OCCOCCOC)=O

InChI

1S/C15H26O10S2/c1-12(25-13(17)11-16)14(18)22-7-9-26-27-10-8-24-15(19)23-6-5-21-4-3-20-2/h12,16H,3-11H2,1-2H3

InChI key

DPMVWUUTGXWXPV-UHFFFAOYSA-N

Application

PEG-SS-PLGA is a redox responsive, biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly(lactide-alternative-glycolide) (PLGA) block, with a reducible disulfide linkage between blocks. This polymer can be fabricated into Glutathione (GSH) responsive nanoparticles which can be used as an intracellular drug delivery system.

Different from common Poly(lactide-co-glycolide) (PLGA) polymer, the lactic and glycolic units in Poly(lactide-alt-glycolide) block alternate in sequence in the polymer chain, and the molar ratio of lactic to glycolic units in the polymer is exactly 1:1.

Poly(lactide-alt-glycolide) exhibits excellent solubility in common organic solvents, such as acetonitrile, acetone, dioxane, DCM, and THF, providing great convenience for drug delivery researches and applications.


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.


Claudia Conte et al.
Journal of controlled release : official journal of the Controlled Release Society, 277, 126-141 (2018-03-15)
In the treatment of lung cancer, there is an urgent need of innovative medicines to optimize pharmacological responses of conventional chemotherapeutics while attenuating side effects. Here, we have exploited some relatively unexplored subtle differences in reduction potential, associated with cancer
Lin Yu et al.
Biomacromolecules, 12(4), 1290-1297 (2011-03-03)
This paper reports the influence of sequence structures of block copolymers composed of poly(lactic acid-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) on their thermogelling aqueous behaviors. A series of thermogelling PLGA-PEG-PLGA triblock copolymers with similar chemical compositions and block lengths



全球贸易项目编号

货号GTIN
926248-1G04065267918204